Shiho Ishizuka
Kumamoto, 8608556, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
The expression of PD-1 ligand 1 on macrophages and its clinical impacts and mechanisms in lung adenocarcinoma.
Journal: Cancer immunology, immunotherapy : CII
Published: November 07, 2021
Non-small-cell Lung Cancer with Severe Skin Manifestations Related to Radiation Recall Dermatitis after Atezolizumab Treatment.
Journal: Internal medicine (Tokyo, Japan)
Published: February 14, 2020
Association of Probiotic Clostridium butyricum Therapy with Survival and Response to Immune Checkpoint Blockade in Patients with Lung Cancer.
Journal: Cancer immunology research
Published: February 09, 2020
Small Cell Lung Cancer Derived from Adenocarcinoma with Mutant Epidermal Growth Factor Receptor Provides a Signature of Transcriptional Alteration in Tumor Cells.
Journal: Internal medicine (Tokyo, Japan)
Published: July 12, 2019
Disorder of Coagulation-Fibrinolysis System: An Emerging Toxicity of Anti-PD-1/PD-L1 Monoclonal Antibodies.
Journal: Journal of clinical medicine
Published: May 03, 2019
Reversible Restrictive Lung Disease in Pseudomesotheliomatous Carcinoma in a Lung Harboring a HER2-mutation.
Journal: Internal medicine (Tokyo, Japan)
Published: March 13, 2018
Successful treatment by pembrolizumab in a patient with end-stage renal disease with advanced non-small cell lung cancer and high PD-L1 expression.
Journal: Respiratory investigation
Published: January 22, 2018
Long-term complete response to carboplatin plus paclitaxel combined with bevacizumab in a patient with metastatic spindle cell carcinoma.
Journal: Respiratory investigation
Published: May 19, 2017
Showing 1-9 of 9
Last Updated: 09/26/2026